{"id":79770,"date":"2026-04-20T12:05:00","date_gmt":"2026-04-20T12:05:00","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/covation-biomaterials-first-commercial-plant-for-biothf-and-bioptmeg-reaches-mechanical-completion-xatryx%ef%bc%8cbrand-unveiled-for-new-non-food-bioptmeg\/"},"modified":"2026-04-20T12:05:00","modified_gmt":"2026-04-20T12:05:00","slug":"covation-biomaterials-first-commercial-plant-for-biothf-and-bioptmeg-reaches-mechanical-completion-xatryx%ef%bc%8cbrand-unveiled-for-new-non-food-bioptmeg","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/covation-biomaterials-first-commercial-plant-for-biothf-and-bioptmeg-reaches-mechanical-completion-xatryx%ef%bc%8cbrand-unveiled-for-new-non-food-bioptmeg\/","title":{"rendered":"Covation Biomaterials’ First Commercial Plant for bioTHF and bioPTMEG Reaches Mechanical Completion; Xatryx\u00ae\uff0cBrand Unveiled for New Non-Food bioPTMEG"},"content":{"rendered":"
\n

SHANGHAI<\/span>, April 20, 2026<\/span> \/PRNewswire\/ —\u00a0Covation Biomaterials LLC (“CovationBio\u00ae<\/sup>“), a biomaterials company with advanced technology in the bio-based materials industry, announced today<\/span> that its first commercial plant for\u00a0the C4 product platform, including\u00a0bioTHF and bio-based polytetramethylene ether glycol (“PTMEG”), achieved mechanical completion in April 2026. In addition, CovationBio now officially launches the Xatryx\u00ae <\/sup>brand for the portfolio of new, non-food, bioPTMEG products to be produced at the plant.<\/p>\n

\n

\"\" <\/a>
<\/span><\/p>\n<\/p><\/div>\n

This milestone marks a significant step forward in defossilization of material production, reinforcing the company’s commitment to delivering high-performance, renewable-based solutions to the global market.<\/p>\n

The C4 facility is located in Qidong, Jiangsu Province, China. It utilizes an innovative, new-to-the-world process technology developed by CovationBio. With a total investment of RMB 10 billion, the plant is planned in three phases, targeting a future total capacity of 500,000 tons per year of bio-based materials. The first phase, which is now mechanically complete, has a 50,000-ton-per-year commercial production capacity for both bioTHF and bioPTMEG. Commercial production is expected to begin in the second half of 2026.<\/p>\n

Feifeng You, President of CovationBio, commented:<\/b>
“The Xatryx\u00ae<\/sup> name conveys our spirit of relentless exploration to develop processes and products that deliver high performance and support defossilization of the materials industry. As an important building block, Xatryx\u00ae<\/sup> products provide many possibilities to improve one’s quality of life while taking good care of our planet. To achieve this, we leverage an abundant, non-food, agricultural by-product that is directly converted to a chemical feedstock, which our Advanced ThermoChemical technology uses to create Xatryx\u00ae<\/sup> products.”<\/p>\n

A Sustainable Alternative to Fossil-Based PTMEG and not Competing with Food Sources<\/b>\u00a0<\/p>\n

As a second-generation bio-based material, Xatryx\u00ae<\/sup> bioPTMEG serves as a drop-in replacement to fossil-based PTMEG, helping customers reduce their reliance on non-renewable materials while maintaining the high-performance of our downstream material applications such as spandex, polyurethanes, and thermoplastic elastomers.<\/p>\n

Key sustainability benefits of Xatryx\u00ae<\/sup> bioPTMEG include:<\/p>\n